Keyphrases
Germ Cell Tumor
100%
Intersex Gonad
100%
Tumor Development
50%
Disorders of Sex Development
50%
Germ Cells
33%
High Risk
33%
Maturation Delay
33%
Recent Advances
16%
Intermediate Risk
16%
Low Risk
16%
In Situ
16%
Malignant Transformation
16%
Transcription Factor E3 (TFE3)
16%
Patient Demographics
16%
Gonadoblastoma
16%
Patient Management
16%
Cell Maturation
16%
Neoplasia
16%
Intersex Disorders
16%
Correct Diagnosis
16%
Undifferentiated Gonadal Tissue
16%
Gonadal Differentiation
16%
Testis-specific Proteins
16%
Neoplastic Lesions
16%
New Classification System
16%
Gene Products
16%
Preneoplastic Lesions
16%
Early Change
16%
Diagnosis-related Groups
16%
Octamer Transcription Factor 1
16%
Immunology and Microbiology
Prevalence
100%
Gonad
100%
Cell Maturation
50%
Maturation
50%
Nomenclature
50%
Gonad Development
50%
Gene Product
50%
Octamer Transcription Factor 4
50%
Testis Development
50%
Medicine and Dentistry
Germinoma
100%
Gonad
100%
Disorders of Sex Development
50%
Neoplasm
33%
Prevalence
33%
Disease
16%
Diagnosis
16%
Malignant Transformation
16%
Protein
16%
Patient Population
16%
Maturation
16%
Gonadoblastoma
16%
Cell Maturation
16%
Gene Product
16%
Octamer Transcription Factor 4
16%
Gonad Development
16%
Testis Development
16%
Biochemistry, Genetics and Molecular Biology
Prevalence
100%
Malignant Transformation
50%
Maturation
50%
Cell Maturation
50%
Nomenclature
50%
Testis Development
50%
Octamer Transcription Factor 4
50%
Gene Product
50%
Gonad Development
50%
Neuroscience
Protein
100%
Octamer Transcription Factor 4
100%
Cell Maturation
100%
Gene Product
100%
Pharmacology, Toxicology and Pharmaceutical Science
Germ Cell Tumor
100%
Disorders of Sex Development
50%
Neoplasm
33%
Prevalence
33%
Disease
16%
Malignant Transformation
16%
Gonadoblastoma
16%
Octamer Transcription Factor 4
16%
Protein
16%